The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games

SHS Huang, K Johnson, AL Pipe - Clinical Journal of Sport …, 2006 - journals.lww.com
Objective: To learn more about the prevalence of dietary supplement and medication use by
Canadian athletes in the Olympic Games in Atlanta 1996 and Sydney 2000. Setting and …

[HTML][HTML] Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab

…, S Leppington, L Bakovic, SHS Huang… - British Journal of …, 2022 - ncbi.nlm.nih.gov
1Department of Internal Medicine, Teikyo University School of Medicine, 2Department of
Hematology/Oncology, Teikyo University School of Medicine and 3Department of Pathology, …

Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study

SHS Huang, K Pavenski, TY Lee… - Blood …, 2021 - ashpublications.org
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening
disorder of systemic microthrombosis and organ ischemia. The etiology of chronic …

Minimum mycophenolic acid levels are associated with donor‐specific antibody formation

…, K Bax, AC Alvarez‐Elías, SHS Huang… - Pediatric …, 2016 - Wiley Online Library
Although de novo DSA are associated with inferior graft survival, there are no effective
strategies to prevent their formation. Underexposure to MPA (prodrug: MMF ) also contributes to …

The Kinetics of Cystatin C: A Marker for Dialysis Adequacy

HS Shih-Han - 2015 - search.proquest.com
When 90% or more of native kidney function is lost, renal replacement therapy must be
initiated to sustain life. Renal transplantation is the preferred method, but availability is limited. …

Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease

G Filler, D Liu, SHS Huang, S Casier, LA Chau… - Clinical …, 2011 - Elsevier
OBJECTIVES: It is unclear whether fibroblast growth factor-23 (FGF-23) increases in response
to phosphate accumulation or to decrease clearance in chronic kidney disease (CKD) as …

S305: Phase 2 randomized, placebo-controlled, double-blind, multicenter study of recombinant ADAMTS13 in patients with immune-mediated thrombotic …

…, P Coppo, L Cuccia, T Dutt, SHS Huang… - …, 2023 - journals.lww.com
Background: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare disorder
caused by a severe ADAMTS13 deficiency, due to anti-ADAMTS13 autoantibodies. iTTP …

Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura

K Pavenski, SHS Huang… - Expert Review of …, 2021 - Taylor & Francis
Introduction Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare
autoimmune blood disorder, which presents with microangiopathic hemolytic anemia, …

Cystatin C for the assessment of GFR in neonates with congenital renal anomalies

G Filler, J Grimmer, SHS Huang… - Nephrology Dialysis …, 2012 - academic.oup.com
It is well-established that the long-term prognosis of renal function in neonates depends
largely on their nephron endowment [1]. There is also an increased appreciation that the …

Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy

…, D Delsart, A Akbari, SHS Huang… - The Journal of …, 2024 - academic.oup.com
Context X-linked hypophosphatemia (XLH) is a rare genetic disorder that results in increased
plasma levels of fibroblast growth factor 23 (FGF23). Several studies have demonstrated a …